NCT03857958

Brief Summary

The purpose of this study was to compare the difference in the stent patency duration between side-by-side fully covered self-expanding metal stents (SEMS) and side-by-side plastic stents in patients with malignant hilar biliary obstruction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2019

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

February 27, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 28, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

April 4, 2019

Status Verified

April 1, 2019

Enrollment Period

1.9 years

First QC Date

February 27, 2019

Last Update Submit

April 3, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Duration of stent patency

    The period from the insertion of the stent to the point at which stent revision is required.

    9 months after randomization.

Study Arms (2)

FCSEMS

EXPERIMENTAL

In patients with malignant hilar biliary obstruction, endoscopic drainage is performed for biliary drainage. Since intrahepatic bile ducts are separated, it is preferable to insert a stent into bilateral intrahepatic bile ducts for bile drainage if possible. In FCSEMS group, patients are inserted with Fully covered self-expandable metal stent (FCSEMS) bilaterally for malignant hilar biliary stricture via endoscopic retrograde cholangio-pancreatography.

Procedure: endoscopic retrograde cholangio-pancreatography

Plastic stent

ACTIVE COMPARATOR

In patients with malignant hilar biliary obstruction, endoscopic drainage is performed for biliary drainage. Since intrahepatic bile ducts are separated, it is preferable to insert a stent into bilateral intrahepatic bile ducts for bile drainage if possible. In plastic stent group, patients are inserted with plastic stents bilaterally for malignant hilar biliary stricture.

Procedure: endoscopic retrograde cholangio-pancreatography

Interventions

In patients who were identified to have malignant hilar biliary obstruction, bilateral stents insertion is attempted via ERCP. There will be two groups divided by stent material; FCSEMS and Plastic stent.

Also known as: Plastic stent, FCSEMS
FCSEMSPlastic stent

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Unresectable malignant hilar biliary stricture requiring biliary drainage through endoscopic procedure

You may not qualify if:

  • If endoscopy is not possible based on the judgement of the researcher
  • Life expectancy less than 6 months
  • Acute cholecystitis
  • Previous history of percutaneous transhepatic biliary drainage
  • Previous history of metal stent placement for malignant biliary stricture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

RECRUITING

Study Officials

  • Seoul National University Hospital Seoul National University Hospital, MD, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Woo Hyun Paik, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2019

First Posted

February 28, 2019

Study Start

February 15, 2019

Primary Completion

December 31, 2020

Study Completion

June 30, 2021

Last Updated

April 4, 2019

Record last verified: 2019-04

Locations